Product Overview

Currently there is no treatment for Parkinson’s Disease, only drugs that address symptoms. We aim to gain a better understanding of the disease biology to alter the relentless progression of disability. By assembling a clinical omics dataset of several thousand participants, which includes Whole Genome Sequence (WGS), multi-omic and detailed, longitudinal clinical data, our goal is to discover low frequency, high impact genetic variant that may reveal druggable pathways for treatment or prevention of progression.



To learn more, download the datasheet below: